About Globela Pharma
Globela Pharma is a company based in Surat (India) founded in 1996. Globela Pharma has raised $11.37 million across 3 funding rounds from investors including Somerset Indus Capital Partners, Karthic Jayaraman and Firoze Jehangir Irani. The company has 150 employees as of March 08, 2025. Globela Pharma offers products and services including Finished Dosage Formulations, APIs, Intermediates, and DC Granules and Pellets. Globela Pharma operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Surat, India
- Employees 150 as on 08 Mar, 2025
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Globela Pharma Pvt Ltd
- Jurisdiction Surat, Gujarat, India
-
Annual Revenue
$30.53 M (USD)26.6as on Mar 31, 2024
-
Net Profit
-$797.81 K (USD)-227.12as on Mar 31, 2024
-
EBITDA
$2.19 M (USD)-10.54as on Mar 31, 2024
-
Total Equity Funding
$11.37 M (USD)
in 3 rounds
-
Latest Funding Round
$3.39 M (USD), Unspecified
Jan 11, 2022
-
Investors
Somerset Indus Capital Partners
& 7 more
-
Employee Count
150
as on Mar 08, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Globela Pharma
Globela Pharma offers a comprehensive portfolio of products and services, including Finished Dosage Formulations, APIs, Intermediates, and DC Granules and Pellets.
High-quality drugs for therapeutic areas like oncology
Raw materials for drug manufacturing and innovation
Semi-finished products for pharmaceutical applications
Components for drug production and delivery systems
People of Globela Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of Globela Pharma
Globela Pharma has successfully raised a total of $11.37M across 3 strategic funding rounds. The most recent funding activity was a Unspecified round of $3.39 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Globela Pharma
Globela Pharma has secured backing from 8 investors, including venture fund and angel investors. Prominent investors backing the company include Somerset Indus Capital Partners, Karthic Jayaraman and Firoze Jehangir Irani.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments focused on accessibility, affordability, and ESG integration in India.
|
Locked | Locked | Locked | |
|
KJ
Karthic Jayaraman |
Angel investor and tech entrepreneur, co-founder of WayCool Foods, focused on agritech.
|
Locked | Locked | Locked |
|
FJ
Firoze Jehangir Irani |
-
|
Locked | Locked | Locked |
Investor details for Globela Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Globela Pharma
Investment portfolio details for Globela Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Globela Pharma
Detailed financials for Globela Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Globela Pharma Comparisons
Peer comparison for Globela Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Globela Pharma
Globela Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Globela Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Globela Pharma
Complete news archive for Globela Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Globela Pharma
Globela Pharma was founded in 1996 and raised its 1st funding round 15 years after it was founded.
Globela Pharma is headquartered in Surat, India. It is registered at Surat, Gujarat, India.
Bhanu Vaghashia is the current CEO of Globela Pharma.
Globela Pharma is a funded company, having raised a total of $11.37M across 3 funding rounds to date.
As of Mar 08, 2025, the latest employee count at Globela Pharma is 150.
Annual revenue of Globela Pharma is $30.53M as on Mar 31, 2024.
Globela Pharma was established in 1996 in Surat, India, within the pharmaceutical sector. Various finished formulations, including tablets, capsules, syrups, and injectables, are produced across therapeutic areas such as antibiotics, analgesics, cardiovascular drugs, anticancer treatments, gastrointestinal remedies, multivitamins, and additional categories. Manufacturing operations are supported by facilities certified under ISO 9001:2015 and WHO-GMP standards.
Globela Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Globela Pharma offers Finished Dosage Formulations, APIs, Intermediates, and DC Granules and Pellets.
Globela Pharma has 8 investors. Key investors include Somerset Indus Capital Partners, Karthic Jayaraman, Firoze Jehangir Irani, Rasik M Gondalia, and Biren V Gondaliya.
The valuation of Globela Pharma is $51.09M as of Jan 2022.